November 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Monday that its sales revenue fell by an annual 5% in the first ten months of the year.
Both Sopharma's exports and domestic sales declined by 5% year-on-year each, the drug maker said in a bourse filing.
In October alone, Sopharma's sales revenue fell 16% year-on-year. Exports decreased 11%, while domestic sales lost 23%.
The company did not disclose information about the volume of its sales or amount of sales revenue.
In January-September, Sopharma's non-consolidated sales fell by 3.7% to 152.1 million levs ($88.4 million/77.8 million euro), according to the company's interim financial statement.
As at 12:10 CET on Monday, Sopharma shares traded 0.79% lower at 3.77 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)